Location History:
- Navarra, ES (2010)
- Pamplona-Navarra, ES (2012)
Company Filing History:
Years Active: 2010-2012
Title: Innovations by Javier Dotor De Las Herrerías: Advancements in Biomedicine
Introduction: Javier Dotor De Las Herrerías, an accomplished inventor based in Pamplona-Navarra, Spain, has made significant contributions to the field of biomedicine. With two patents to his name, Dotor De Las Herrerías is recognized for his innovative approaches to addressing critical health issues through peptide technology.
Latest Patents: Among his latest patents are groundbreaking inventions related to peptides that interact with pivotal cytokines. The first patent focuses on "Peptides with capacity for binding with interleukine 10 (IL-10)." This invention outlines peptides that bind to IL-10, offering potential therapies for clinical conditions associated with excessive IL-10 expression, including infectious diseases, tumors, cancers, and acute damage situations. The second patent, titled "Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)," details peptides designed to inhibit the biological activity of TGF-β1. These peptides may be utilized in treating diseases characterized by excessive or dysregulated TGF-β1 expression.
Career Highlights: Javier Dotor De Las Herrerías is currently associated with Proyecto De Biomedicina Cima S.L., where he continues to pursue advancements in peptide therapeutics. His work is pivotal in bridging gaps in treatment options for various pathological conditions.
Collaborations: Dotor De Las Herrerías collaborates with notable colleagues in the field, including Lorea Manterola Careaga and Inés Noelia Casares Lagar. Together, they contribute to the advancement of biomedicine, leveraging their expertise to foster innovative solutions.
Conclusion: As an influential inventor, Javier Dotor De Las Herrerías exemplifies the spirit of innovation in the biomedical sector. His patents not only showcase his ingenuity but also hold promise for transformative treatments, potentially impacting countless lives globally. The work he undertakes at Proyecto De Biomedicina Cima S.L. marks a significant stride towards addressing pressing medical challenges.